Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer

NCT02379039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2023-12-22

No results posted yet for this study

Summary

The study's aim is to define imaging and molecular bio-markers for prediction of radiotherapy response of squamous cell carcinomas, in an early treatment phase.

Conditions

Sponsors & Collaborators

  • Lund University

    collaborator OTHER
  • Umeå University

    lead OTHER

Principal Investigators

  • Björn Zackrisson, Professor · Umeå University, Department of Radiation Sciences - Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02379039 on ClinicalTrials.gov